IRadimed Corporation
IRMD | NASDAQ
$82.46
+$0.34 (+0.41%)
At close: Sep 21, 2026, 4:00 PM ET
$82.29
-$0.17 (-0.21%)
Pre-market:
Sep 22, 2026, 9:25 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 83.81M | 73.24M | 65.56M | 53.3M | 41.81M | 31.72M |
Cost of Revenue | 19.49M | 16.89M | 15.4M | 12.02M | 9.76M | 8.14M |
Gross Profit | 64.32M | 56.35M | 50.16M | 41.28M | 32.05M | 23.57M |
Operating Income | 26.15M | 21.96M | 20.04M | 15.63M | 9.82M | -756.09K |
Interest Income | n/a | 2.19M | 1.86M | 581.85K | 34.81K | 132.19K |
Pretax Income | 28.36M | 24.28M | 21.74M | 16.18M | 9.84M | -616.88K |
Net Income | 22.48M | 19.23M | 17.19M | 12.83M | 9.33M | 1.37M |
Selling & General & Admin | 35.2M | 31.55M | 27.26M | 23.38M | 20.33M | 22.43M |
Research & Development | 2.98M | 2.83M | 2.86M | 2.28M | 1.91M | 1.9M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 38.18M | 34.39M | 30.12M | 25.65M | 22.23M | 24.33M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 17.42M | 15.62M | 12.14M | 12.68M | 10.56M | 10.16M |
Cost & Expenses | 57.67M | 51.28M | 45.53M | 37.68M | 32M | 32.47M |
Income Tax Expense | 5.88M | 5.04M | 4.55M | 3.35M | 510.82K | -1.99M |
Shares Outstanding (Basic) | 12.72M | 12.67M | 12.6M | 12.56M | 12.35M | 12.12M |
Shares Outstanding (Diluted) | 12.85M | 12.78M | 12.72M | 12.64M | 12.59M | 12.44M |
EPS (Basic) | 1.77 | 1.52 | 1.36 | 1.02 | 0.76 | 0.11 |
EPS (Diluted) | 1.75 | 1.50 | 1.35 | 1.02 | 0.74 | 0.11 |
EBITDA | 30.74M | 25.09M | 22.5M | 16.85M | 11.24M | 582.73K |
EBIT | 28.36M | 24.28M | 21.74M | 16.18M | 9.84M | -756.09K |
Depreciation & Amortization | 2.38M | 817.66K | 765.18K | 670.67K | 1.41M | 1.34M |
Add to Watchlist
Select watchlists to add or remove IRMD